Passage BIO annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
Passage BIO Capital Expenditures (CapEx) Growth & History (PASG)
Passage BIO's capital expenditures (capex) was $34,000 for fiscal 2024.
View full Passage BIO company overviewPassage BIO annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $34,000 | −$112,000 | −76.71% |
| 2023 | 2023-12-31 | $146,000 | −$5.1M | −97.23% |
| 2022 | 2022-12-31 | $5.3M | −$20.4M | −79.43% |
| 2021 | 2021-12-31 | $25.6M | $24.0M | +1457.84% |
| 2020 | 2020-12-31 | $1.6M | −$47,000 | −2.78% |
| 2019 | 2019-12-31 | $1.7M | — | — |
Passage BIO quarterly capital expenditures (capex)
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $14,000 | $1,000 | +7.69% |
| Q4 2023 | 2023-12-31 | $13,000 | −$461,000 | −97.26% |
| Q3 2023 | 2023-09-30 | $4,000 | −$1.7M | −99.77% |
| Q2 2023 | 2023-06-30 | $103,000 | −$728,000 | −87.61% |
| Q1 2023 | 2023-03-31 | $26,000 | −$2.2M | −98.83% |
| Q4 2022 | 2022-12-31 | $474,000 | −$6.8M | −93.52% |
| Q3 2022 | 2022-09-30 | $1.7M | −$9.8M | −84.85% |
| Q2 2022 | 2022-06-30 | $831,000 | −$4.7M | −84.92% |
| Q1 2022 | 2022-03-31 | $2.2M | $924,000 | +71.02% |
| Q4 2021 | 2021-12-31 | $7.3M | $6.0M | +461.27% |
| Q3 2021 | 2021-09-30 | $11.5M | $11.4M | +7626.17% |
| Q2 2021 | 2021-06-30 | $5.5M | $5.4M | +5761.70% |
| Q1 2021 | 2021-03-31 | $1.3M | $1.2M | +1214.14% |
| Q4 2020 | 2020-12-31 | $1.3M | $761,000 | +140.15% |
| Q3 2020 | 2020-09-30 | $149,000 | $40,000 | +36.70% |
| Q2 2020 | 2020-06-30 | $94,000 | −$63,000 | −40.13% |
| Q1 2020 | 2020-03-31 | $99,000 | −$785,000 | −88.80% |
| Q4 2019 | 2019-12-31 | $543,000 | — | — |
| Q3 2019 | 2019-09-30 | $109,000 | — | — |
| Q2 2019 | 2019-06-30 | $157,000 | — | — |
| Q1 2019 | 2019-03-31 | $884,000 | — | — |
Passage BIO capital expenditures (capex) trends
Over the last five fiscal years, Passage BIO's capital expenditures (capex) decreased from $1.7M to $34,000, a change of −$1.7M. The latest reported quarter, Q4 2024, shows $14,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Passage BIO source filings ↗